SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367920-16-000022
Filing Date
2016-04-14
Accepted
2016-04-14 07:35:58
Documents
3
Period of Report
2016-04-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kxchristivanheek.htm 8-K 31987
2 EXHIBIT 99.1 exhibit991-christivanheek.htm EX-99.1 9496
3 concertimage8ka02.jpg GRAPHIC 15744
  Complete submission text file 0001367920-16-000022.txt   64613
Mailing Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36310 | Film No.: 161570441
SIC: 2834 Pharmaceutical Preparations